NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Strategy
MSTR
5
Palantir
PLTR
US Stock MarketDetailed Quotes
RADX Radiopharm Theranostics
- 5.500
- +0.500+10.00%
Close Mar 3 16:00 ET
- 5.510
- +0.010+0.18%
Pre 08:49 ET
42.79MMarket Cap-0.24P/E (TTM)
11.000High5.025Low7.70MVolume5.180Open5.000Pre Close62.50MTurnover149.45%Turnover RatioLossP/E (Static)7.78MShares50.82052wk High2.44P/B28.32MFloat Cap3.55052wk Low--Dividend TTM5.15MShs Float50.820Historical High--Div YieldTTM119.50%Amplitude3.550Historical Low8.120Avg Price1Lot Size
About Radiopharm Theranostics Company
Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.
Company Profile
SymbolRADX
Company NameRadiopharm Theranostics
Founded2021
CEOMr. Riccardo Canevari
MarketNASDAQ
Securities TypeDR
ADS Ratio1.0 : 300.0
Fiscal Year Ends06-30
Address62 Lygon Street,Level 3
CityCarlton
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3053
Phone61-3-9824-5254
Company Executives
- Name
- Position
- Salary
- Riccardo Canevari
- Chief Executive Officer and Managing Director
- --
- Phillip A. Hains
- Director, Chief Financial Officer and Company Secretary
- --
- Dr. Thomas H. Tulip
- Chief Business Officer
- --
- Dr. Dimitris Voliotis, M.D.
- Chief Medical Officer
- --
- Paul E Hopper
- Executive Chairman of the Board
- --
- Ian Turner
- Director
- --
- Dr. Leila Alland, M.D.
- Director
- --
- Noel Donnelly, M.B.A.
- Independent Director
- --
- Hester Larkin
- Independent Director
- --